bisreports Reports

The global prostate cancer testing market was valued at $5,246.9 million in 2021, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.

The global wearable patches market is projected to reach $26,892.7 million by 2031, growing at a CAGR of 11.06% during the forecast period 2022-2031.

The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032.

The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.

The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.

The Middle East and North Africa laparoscopy devices market is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.

The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.

The global minimally invasive neurosurgical systems market was valued at $419.8 million in 2019 and is anticipated to reach $1,217.4 million by 2030, growing at a CAGR of 11.9% during the forecast period 2020-2030.

The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030. The market is driven by certain factors, including the increasing global geriatric population, increasing incidence of chronic diseases including autoimmune disorders, and rise in demand for self-injectable systems.

The artificial intelligence in healthcare is expected to grow at a CAGR of 24.40% during the forecast period from 2021 to 2030.

The surgical microscopes market report highlights that the overall surgical microscopes market was valued at $928.3 million in 2020 and is expected to reach $3,578.2 million by the end of 2031. The market is expected to grow at a CAGR of 13.3% during the forecast period from 2021 to 2031.

In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.

The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.

The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031.

The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031. The market is driven by factors such as the increasing prevalence of gastrointestinal diseases, rising preference for minimally invasive surgeries, growing demand for capsule endoscopy, the shift from reusable endoscopes to disposable endoscopes, and technological advancements in the field of robot-assisted endoscopes and AI-based devices.

Next-Generation Gynecological Cancer Diagnostics market to grow at a significant CAGR of 10.07% during 2020-2031.The Market is expected to reach $5,657.7 Million by 2031. Next-Generation Gynecological Cancer Diagnostics market report by BIS Research provides deep market insight, industry analysis, trends & forecast to 2031 that will help your business to grow.

The global nucleic acid isolation and purification market was estimated at $2,304.7 Million in 2020 and is expected to grow at a CAGR of 7.20% from 2021 to 2031.

MR imaging in neurosurgery market was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031.

This report will help companies involved in research and development of PD-1/PDL-1 inhibitors to understand the opportunity as well as competition in the segment as well it help venture capital investment firms to make informed decisions on their investment in PD-1/PDL-1 inhibitor therapeutics segment.

The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.

In 2021, the global NGS library preparation automation market was valued at $1,273.2 million, and it is expected to reach $3,803.3 million by 2029, growing at a CAGR of 14.85% during the forecast period 2022-2029.

The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.

The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.